Form 8-K - Current report:
SEC Accession No. 0001159036-23-000017
Filing Date
2023-03-13
Accepted
2023-03-13 08:47:04
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K halo-20230310.htm   iXBRL 8-K 42552
  Complete submission text file 0001159036-23-000017.txt   179731

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20230310.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20230310_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20230310_pre.xml EX-101.PRE 12520
6 EXTRACTED XBRL INSTANCE DOCUMENT halo-20230310_htm.xml XML 10844
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 23725859
SIC: 2836 Biological Products, (No Diagnostic Substances)